A prospective evaluation of efficacy and safety of topical bromfenac 0.09% over topical flurbiprofen 0.03% after cataract surgery
dc.contributor.author | Hebbar, Sahana K. | en_US |
dc.contributor.author | P., Deepak | en_US |
dc.contributor.author | G. K., Nalini | en_US |
dc.contributor.author | C. V., Kavitha | en_US |
dc.contributor.author | G. N., Sahana | en_US |
dc.contributor.author | Nagaral, Jayashree V. | en_US |
dc.date.accessioned | 2020-04-23T07:53:54Z | |
dc.date.available | 2020-04-23T07:53:54Z | |
dc.date.issued | 2019-02 | |
dc.description.abstract | Background: Different medications are used to reduce pain and inflammation after cataract surgery. Hence this study was taken up to compare the efficacy and safety of topical bromfenac 0.09% over topical flurbiprofen 0.03% in reducing anterior chamber inflammation and pain after cataract surgery.Methods: Total of 100 patients who underwent uneventful cataract surgery with posterior chamber intra ocular lens (IOL) implantation were randomly allocated to receive bromfenac 0.09% and flurbiprofen 0.03% topically from first post-operative day onwards for 6 weeks. Assessment of anterior chamber inflammation and pain was done by slit lamp and visual analogue scale respectively on each follow up days. Analysis was done by unpaired t test and Fischer’s exact test.Results: The response to treatment was earlier in bromfenac group for all the inflammatory changes (significant difference was found on day 7, p<0.05) except for corneal edema where both the groups showed similar response. On 7th day after surgery, 72% patients in flurbiprofen group and 12% in bromfenac group had pain (score1), while on the 14th day none in the bromfenac group complained of pain whereas 4% in flurbiprofen group still had pain. Both the drugs were safe and no clinically serious adverse effects were observed in either of the groups.Conclusions: This study showed both the medications, topical bromfenac 0.09% and topical flurbiprofen 0.03% effective and safe in reducing pain and anterior chamber inflammation after cataract surgery but the response was earlier with bromfenac 0.09%. | en_US |
dc.identifier.affiliations | Department of Pharmacology, HIMS, Hassan, Karnataka, India | en_US |
dc.identifier.affiliations | Department of Ophthalmology, HIMS, Hassan, Karnataka, India | en_US |
dc.identifier.citation | Hebbar Sahana K., P. Deepak, G. K. Nalini, C. V. Kavitha, G. N. Sahana, Nagaral Jayashree V.. A prospective evaluation of efficacy and safety of topical bromfenac 0.09% over topical flurbiprofen 0.03% after cataract surgery. International Journal of Basic & Clinical Pharmacology. 2019 Feb; 8(2): 234-239 | en_US |
dc.identifier.issn | 2319-2003 | |
dc.identifier.issn | 2279-0780 | |
dc.identifier.place | India | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/200004 | |
dc.language | en | en_US |
dc.publisher | Medip Academy | en_US |
dc.relation.issuenumber | 2 | en_US |
dc.relation.volume | 8 | en_US |
dc.source.uri | https://dx.doi.org/10.18203/2319-2003.ijbcp20190140 | en_US |
dc.subject | Anterior chamber inflammation | en_US |
dc.subject | Bromfenac | en_US |
dc.subject | Flurbiprofen | en_US |
dc.subject | Post-operative pain | en_US |
dc.subject | Prostaglandins | en_US |
dc.title | A prospective evaluation of efficacy and safety of topical bromfenac 0.09% over topical flurbiprofen 0.03% after cataract surgery | en_US |
dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1